U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) insider Eric Joseph Williams sold 2,000 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $95.84, for a total transaction of $191,680.00. Following the sale, the insider now directly owns 14,814 shares of the company’s stock, valued at $1,419,773.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy stock traded down $2.44 during mid-day trading on Tuesday, reaching $92.17. The company’s stock had a trading volume of 111,576 shares, compared to its average volume of 91,789. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63. The company has a current ratio of 1.78, a quick ratio of 1.88 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.39 billion, a price-to-earnings ratio of 100.57, a PEG ratio of 4.40 and a beta of 1.38. The business has a 50 day moving average price of $83.80 and a 200-day moving average price of $91.31.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The firm had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.76 EPS. Sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.
U.S. Physical Therapy Announces Dividend
Institutional Trading of U.S. Physical Therapy
Institutional investors and hedge funds have recently made changes to their positions in the business. Intech Investment Management LLC acquired a new position in U.S. Physical Therapy during the third quarter worth $356,000. First Horizon Advisors Inc. increased its position in shares of U.S. Physical Therapy by 25.1% during the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock worth $126,000 after buying an additional 298 shares during the period. Howe & Rusling Inc. grew its position in shares of U.S. Physical Therapy by 22.5% during the 3rd quarter. Howe & Rusling Inc. now owns 4,864 shares of the company’s stock worth $412,000 after buying an additional 893 shares during the period. Quest Partners LLC boosted its holdings in U.S. Physical Therapy by 2,368.2% in the third quarter. Quest Partners LLC now owns 8,614 shares of the company’s stock worth $729,000 after acquiring an additional 8,265 shares in the last quarter. Finally, Sugar Maple Asset Management LLC acquired a new stake in shares of U.S. Physical Therapy in the 3rd quarter worth about $212,000.
Wall Street Analysts Forecast Growth
USPH has been the topic of a number of recent analyst reports. Bank of America reiterated a “neutral” rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Finally, Barrington Research reiterated an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 7th.
Check Out Our Latest Analysis on U.S. Physical Therapy
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
- Five stocks we like better than U.S. Physical Therapy
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- The 3 Best Fintech Stocks to Buy Now
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.